NFKB1 and prostate carcinoma: In this study, we employed a NF-κB regulated luciferase reporter to identify anti-cancer NF-κB inhibitors in prostate cancer cells and found that Lycorine is a very potent inhibitor of NF-κB in prostate cancer.